Reddit posts revealed unreported drug interactions between cannabis products and immunosuppressants

Social media monitoring found Reddit users reporting dangerous interactions between consumer cannabis products and immunosuppressant medications, including some interactions not previously documented in clinical trials.

Allen, Matthew R et al.·Drug safety·2025·Preliminary EvidenceObservational
RTHC-05912ObservationalPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Searching 63.5 million Reddit posts, researchers identified 190 posts discussing both cannabis-derived products (CDPs) and immunosuppressants. Of these, 66 posts (35%) expressed concern about potential drug-drug interactions, and 4 posts (2%) reported actual adverse interactions. Two of the four matched the known CBD/tacrolimus interaction discovered in Epidiolex trials. Two others reported previously undocumented interactions: a CBD or THC/sirolimus interaction and a THC/tacrolimus interaction, both resulting in drug toxicity.

Key Numbers

63.5 million Reddit posts searched; 190 relevant posts identified; 66 (35%) expressed DDI concern; 4 (2%) reported actual DDI events; 2 novel interactions discovered: CBD/THC with sirolimus and THC with tacrolimus

How They Did This

Searched Reddit for subreddits related to cannabis-derived products or health, yielding 63,561,233 posts. Identified 190 posts discussing both immunosuppressants and CDPs. Two blinded investigators evaluated posts for DDI concerns and reported adverse events.

Why This Research Matters

Consumer cannabis products are unregulated and cannot be tested in clinical trials the way Epidiolex was. This study demonstrates that real-world drug interactions are occurring with consumer CBD and THC products and going unreported to formal pharmacovigilance systems, creating a hidden safety gap.

The Bigger Picture

As cannabis legalization expands while millions of Americans take immunosuppressants for organ transplants, autoimmune diseases, and cancer, the interaction risk grows. Traditional pharmacovigilance misses these events because consumer cannabis products exist outside the regulated pharmaceutical system.

What This Study Doesn't Tell Us

Social media data cannot verify clinical outcomes or confirm causation. Four reported DDI events is a very small number from which to draw conclusions. Reddit users may not accurately describe medications, doses, or outcomes. Cannot estimate the true incidence of these interactions.

Questions This Raises

  • ?How many immunosuppressant patients use consumer cannabis products without informing their physicians?
  • ?Should pharmacovigilance systems formally monitor social media for cannabis-drug interactions?

Trust & Context

Key Stat:
35% of relevant Reddit posts expressed drug interaction concern
Evidence Grade:
Novel pharmacovigilance methodology identifies real safety signals, but social media data cannot verify clinical outcomes or establish interaction mechanisms.
Study Age:
2025 publication
Original Title:
Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug-Drug Interactions Between Immunosuppressants and Cannabis-Derived Products.
Published In:
Drug safety, 48(1), 99-105 (2025)
Database ID:
RTHC-05912

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

What interactions were found?

Four Reddit users reported drug toxicity from combining cannabis products with immunosuppressants. Two involved the known CBD/tacrolimus interaction, while two were novel: a CBD or THC/sirolimus interaction and a THC/tacrolimus interaction.

Why are these interactions dangerous?

Immunosuppressants have narrow therapeutic windows, meaning small changes in blood levels can cause toxicity or organ rejection. Cannabis products can alter how these drugs are metabolized, pushing blood levels into dangerous ranges.

Read More on RethinkTHC

Cite This Study

RTHC-05912·https://rethinkthc.com/research/RTHC-05912

APA

Allen, Matthew R; Wightman, Gwenyth Portillo; Zhu, Zechariah; Poliak, Adam; Smith, Davey M; Dredze, Mark; Ayers, John W. (2025). Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug-Drug Interactions Between Immunosuppressants and Cannabis-Derived Products.. Drug safety, 48(1), 99-105. https://doi.org/10.1007/s40264-024-01481-x

MLA

Allen, Matthew R, et al. "Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug-Drug Interactions Between Immunosuppressants and Cannabis-Derived Products.." Drug safety, 2025. https://doi.org/10.1007/s40264-024-01481-x

RethinkTHC

RethinkTHC Research Database. "Pharmacovigilance in the Age of Legalized Cannabis: Using So..." RTHC-05912. Retrieved from https://rethinkthc.com/research/allen-2025-pharmacovigilance-in-the-age

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.